BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2014 6:38:00 PM | Browse: 910 | Download: 680
Publication Name World Journal of Gastroenterology
Manuscript ID 7239
Country China
Received
2013-11-10 12:43
Peer-Review Started
2013-11-13 11:56
To Make the First Decision
2014-02-28 18:32
Return for Revision
2014-03-07 18:23
Revised
2014-03-15 18:58
Second Decision
2014-05-26 16:20
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-26 16:43
Articles in Press
2014-05-26 17:38
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-06-06 22:24
Typeset the Manuscript
2014-07-27 14:09
Publish the Manuscript Online
2014-08-20 18:38
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Retrospective Study
Article Title Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation
Manuscript Source Invited Manuscript
All Author List Guang-qin Xiao, Jiu-lin Song, Shu Shen, Jia-yin Yang and Lu-nan Yan
Funding Agency and Grant Number
Funding Agency Grant Number
National Science and Technology Major Project of China 2012ZX10002-016
National Science and Technology Major Project of China 2012ZX10002017-017
Corresponding Author Lu-nan Yan, MD, PhD, Liver Transplantation Center, West China Hospital of Sichuan University, Nanguoxue, xiang No. 37, Wuhou District, Chengdu 610041, Sichuan Province, China. yanlunan1268@163.com
Key Words Hepatocellular carcinoma; Living donor; Deceased donor; Liver transplantation; Hepatitis B virus
Core Tip Whether there is a higher tumor recurrence for living donor liver transplantation (LDLT) than for deceased donor liver transplantation (DDLT) for hepatocellular carcinoma (HCC) has recently become a subject of debate. Our results suggest that LDLT does not increase the tumor recurrence of HCC compared to DDLT. The recurrence-free survival and long-term survival times of LDLT for HCC are higher than those of DDLT.
Publish Date 2014-08-20 18:38
Citation Xiao GQ, Song JL, Shen S, Yang JY, Yan LN. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation. World J Gastroenterol 2014; 20(31): 10953-10959
URL http://www.wjgnet.com/1007-9327/full/v20/i31/10953.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i31.10953
Full Article (PDF) WJG-20-10953.pdf
Full Article (Word) WJG-20-10953.doc
Manuscript File 7239-Review.doc
Answering Reviewers 7239-Answering reviewers.pdf
Copyright License Agreement 7239-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 7239-Language certificate.pdf
Peer-review Report 7239-Peer review(s).pdf
Scientific Misconduct Check 7239-CrossCheck.jpg
Scientific Editor Work List 7239-Scientific editor work list.pdf